{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T17:16:14Z","timestamp":1774113374275,"version":"3.50.1"},"reference-count":42,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2013,3,15]],"date-time":"2013-03-15T00:00:00Z","timestamp":1363305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2013,3,15]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Untreated rabies virus (RABV) infection leads to death. Vaccine and postexposure treatment have been effective in preventing RABV infection. However, due to cost, rabies vaccination and treatment have not been widely used in developing countries. There are 55,000 human death caused by rabies annually. An efficacious and cost-effective rabies vaccine is needed. Parainfluenza virus 5 (PIV5) is thought to contribute to kennel cough, and kennel cough vaccines containing live PIV5 have been used in dogs for many years. In this work, a PIV5-vectored rabies vaccine was tested in mice. A recombinant PIV5 encoding RABV glycoprotein (G) (rPIV5-RV-G) was administered to mice via intranasal (i.n.), intramuscular (i.m.), and oral inoculation. The vaccinated mice were challenged with a 50% lethal challenge dose (LD\n            <jats:sub>50<\/jats:sub>\n            ) of RABV challenge virus standard 24 (CVS-24) intracerebrally. A single dose of 10\n            <jats:sup>6<\/jats:sup>\n            PFU of rPIV5-RV-G was sufficient for 100% protection when administered via the i.n. route. The mice vaccinated with a single dose of 10\n            <jats:sup>8<\/jats:sup>\n            PFU of rPIV5-RV-G via the i.m. route showed very robust protection (90% to 100%). Intriguingly, the mice vaccinated orally with a single dose of 10\n            <jats:sup>8<\/jats:sup>\n            PFU of rPIV5-RV-G showed a 50% survival rate, which is comparable to the 60% survival rate among mice inoculated with an attenuated rabies vaccine strain, recombinant LBNSE. This is first report of an orally effective rabies vaccine candidate in animals based on PIV5 as a vector. These results indicate that rPIV5-RV-G is an excellent candidate for a new generation of recombinant rabies vaccine for humans and animals and PIV5 is a potential vector for oral vaccines.\n          <\/jats:p>","DOI":"10.1128\/jvi.02886-12","type":"journal-article","created":{"date-parts":[[2012,12,27]],"date-time":"2012-12-27T01:35:08Z","timestamp":1356572108000},"page":"2986-2993","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":48,"title":["A Novel Rabies Vaccine Based on a Recombinant Parainfluenza Virus 5 Expressing Rabies Virus Glycoprotein"],"prefix":"10.1128","volume":"87","author":[{"given":"Zhenhai","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Infectious Disease, University of Georgia, Athens, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Georgia, Athens, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiudan","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, University of Georgia, Athens, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoqing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Georgia, Athens, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiping","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Georgia, Athens, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clement W.","family":"Gnanadurai","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Georgia, Athens, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen F.","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Georgia, Athens, Georgia, USA"},{"name":"State-Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biao","family":"He","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, University of Georgia, Athens, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.4.6.1021"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1201-9712(00)90114-0"},{"key":"e_1_3_2_4_2","volume-title":"First report of the WHO Expert Committee on Rabies. Technical Report Series 931","author":"WHO","year":"2005","unstructured":"WHO. 2005. First report of the WHO Expert Committee on Rabies. Technical Report Series 931. WHO, Geneva, Switzerland."},{"key":"e_1_3_2_5_2","volume-title":"World survey for rabies no 35 for the year 1999","author":"WHO","year":"2002","unstructured":"WHO. 2002. World survey for rabies no 35 for the year 1999. Report WHO\/CD\/CSR\/EPH\/2002 10. WHO, Geneva, Switzerland."},{"key":"e_1_3_2_6_2","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia","volume":"83","author":"Knobel DL","year":"2005","unstructured":"KnobelDL CleavelandS ColemanPG FevreEM MeltzerMI MirandaME ShawA ZinsstagJ MeslinFX. 2005. Re-evaluating the burden of rabies in Africa and Asia. Bull. World Health Organ. 83:360\u2013368.","journal-title":"Bull. World Health Organ."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1586\/erv.11.140"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/312163a0"},{"key":"e_1_3_2_9_2","first-page":"1","article-title":"Rationale and prospects for rabies elimination in developing countries","volume":"187","author":"Meslin FX","year":"1994","unstructured":"MeslinFX FisbeinDB MatterHC. 1994. Rationale and prospects for rabies elimination in developing countries. Curr. Top. Microbiol. Immunol. 187:1\u201326.","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.81.22.7194"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.2460\/javma.235.6.691"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010560"},{"key":"e_1_3_2_13_2","first-page":"363","article-title":"Immune response in skunks to a vaccinia virus recombinant expressing the rabies virus glycoprotein","volume":"51","author":"Tolson ND","year":"1987","unstructured":"TolsonND CharltonKM StewartRB CampbellJB WiktorTJ. 1987. Immune response in skunks to a vaccinia virus recombinant expressing the rabies virus glycoprotein. Can. J. Vet. Res. 51:363\u2013366.","journal-title":"Can. J. Vet. Res."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(92)90351-J"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.7589\/0090-3558-44.1.71"},{"key":"e_1_3_2_16_2","first-page":"1204","article-title":"Human vaccinia infection after contact with a raccoon rabies vaccine bait\u2014Pennsylvania 2009","volume":"58","author":"CDC","year":"2009","unstructured":"CDC. 2009. Human vaccinia infection after contact with a raccoon rabies vaccine bait\u2014Pennsylvania 2009. MMWR Morb. Mortal. Wkly. Rep. 58:1204\u20131207.","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.7589\/0090-3558-26.1.99"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.09.033"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2005.04.004"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.16.3.754-759.1977"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2006.12.005"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2006.05.002"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1997.8801"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01552-10"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2009.11.033"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00289-08"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00389-11"},{"key":"e_1_3_2_28_2","volume-title":"Laboratory techniques in rabies","author":"Smith LT","year":"1996","unstructured":"SmithLT YagerPA BaerGM. 1996. A rapid fluorescence focus inhibition test (RFFIT) for determining rabies virus-neutralising antibody. In MeslinFX KaplanMM KoproskiH (ed), Laboratory techniques in rabies, 4th ed. WHO, Geneva, Switzerland.","edition":"4"},{"key":"e_1_3_2_29_2","first-page":"493","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed LJ","year":"1938","unstructured":"ReedLJ MuenchH. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27:493\u2013497.","journal-title":"Am. J. Hyg."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00519-11"},{"key":"e_1_3_2_31_2","volume-title":"Rabies virus","author":"Wunner WH","year":"2002","unstructured":"WunnerWH. 2002. Rabies virus. Academic Press, New York, NY."},{"key":"e_1_3_2_32_2","first-page":"233","article-title":"Studies on an inactivated vaccine against rabies virus in domestic animals","volume":"125","author":"Monaco F","year":"2006","unstructured":"MonacoF FranchiPM LelliR. 2006. Studies on an inactivated vaccine against rabies virus in domestic animals. Dev. Biol. (Basel) 125:233\u2013239.","journal-title":"Dev. Biol. (Basel)"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2006.07.037"},{"key":"e_1_3_2_34_2","first-page":"467","article-title":"Canine adenovirus based rabies vaccines","volume":"131","author":"Tordo N","year":"2008","unstructured":"TordoN FoumierA JalletC SzelechowskiM KlonjkowskiB EloitM. 2008. Canine adenovirus based rabies vaccines. Dev. Biol. (Basel) 131:467\u2013476.","journal-title":"Dev. Biol. (Basel)"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.02.084"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2006.03.027"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(92)90465-2"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(91)90539-N"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02330-12"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050144"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1863-2378.2008.01215.x"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02321-12"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.24.9165"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.02886-12","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.02886-12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T21:46:42Z","timestamp":1646430402000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.02886-12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,15]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,3,15]]}},"alternative-id":["10.1128\/JVI.02886-12"],"URL":"https:\/\/doi.org\/10.1128\/jvi.02886-12","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,15]]},"assertion":[{"value":"2012-10-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-12-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-02-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}